Walgreens Boots Alliance (WBA)
(Delayed Data from NSDQ)
$8.77 USD
+0.03 (0.34%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $8.76 -0.01 (-0.11%) 4:56 PM ET
5-Strong Sell of 5 5
D Value D Growth A Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$8.77 USD
+0.03 (0.34%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $8.76 -0.01 (-0.11%) 4:56 PM ET
5-Strong Sell of 5 5
D Value D Growth A Momentum D VGM
Zacks News
Walgreens Boots Alliance (WBA) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $62.25, marking a -0.75% move from the previous day.
Company News For Nov 12, 2019
by Zacks Equity Research
Companies In The News Are: QRTEA, FOLD, NKTR, WBA, KKR.
Walgreens (WBA) Catches Eye: Stock Jumps 5.1%
by Zacks Equity Research
Walgreens (WBA) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
Walgreens is Heading Toward Private
by Zacks Equity Research
Walgreens is Heading Toward Private
Walgreens (WBA) Buyout Gets Closer
by Mark Vickery
KKR has announced it has made a formal leveraged buyout (LBO) bid to take Walgreens Boots Alliance (WBA) off the NYSE and into private ownership.
Walgreens Boots Alliance (WBA) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $58.67, moving -1.38% from the previous trading session.
Headline Roundup
by Panel Of Zacks Experts
Earnings are in full effect and companies are making moves. Now that the trade war has settled down, it's time to focus on what's important... EARNINGS!
JUUL Continues to Unravel as Altria's (MO) Q3 Earnings Near
by Christopher Vargas
Altria (MO) is set to report its third quarter results on Thursday, October 31 before the opening bell.
Company News For Oct 29, 2019
by Zacks Equity Research
Wall Street closed sharply higher on Monday buoyed by better-than-expected earnings results, possibility of an interim trade deal and positive development on Brexit.
Better-than-expected Q3 Earnings
by Zacks Equity Research
Better-than-expected Q3 Earnings
Tiffany (TIF) for Sale? Plus New Earnings from AT&T, Spotify & Walgreens
by Mark Vickery
Pre-markets appear ready to open in new record territory, with news of a potential Tiffany sale and a bevy of new earnings reports.
Walgreens Boots (WBA) Q4 Earnings Surpass, Margins Fall
by Zacks Equity Research
Growth within the Retail Pharmacy USA and Pharmaceutical Wholesale divisions of Walgreens Boots (WBA) is partially offset by a dull performance at Retail Pharmacy International.
Walgreens Boots Alliance (WBA) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Walgreens (WBA) delivered earnings and revenue surprises of 1.42% and 0.28%, respectively, for the quarter ended August 2019. Do the numbers hold clues to what lies ahead for the stock?
Walgreens Boots Alliance (WBA) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $54.45, moving -0.2% from the previous trading session.
Q3 Earnings Reports to Flood Wall Street This Week
by Zacks Equity Research
Q3 Earnings Reports to Flood Wall Street This Week
Analysts Estimate Walgreens Boots Alliance (WBA) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Walgreens (WBA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is Walgreens Boots (WBA) Likely to Disappoint in Q4 Earnings?
by Zacks Equity Research
Persistent de-emphasizing of tobacco is hurting growth, which should get reflected in the upcoming quarterly results of Walgreens Boots Alliance (WBA).
Opioid Settlement, Boeing Downgrades: Markets Looking Up
by Mark Vickery
Futures are up somewhat in this Monday's pre-market after a sell-off Friday. Much of the sentiment going forward will rely on Q3 results and other news items.
Microsoft, Nuance Team Up to Accelerate Healthcare Delivery
by Zacks Equity Research
Microsoft (MSFT) partners Nuance Communications (NUAN) to deliver robust conversational AI and ambient intelligence technologies to transform doctor-patient interaction.
Walgreens Boots Alliance (WBA) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $54.66, moving +0.27% from the previous trading session.
Walgreens Boots Alliance (WBA) Stock Moves -0.91%: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $52.28, moving -0.91% from the previous trading session.
Walgreens Inks Retail Health Collaboration Deal With Novant
by Zacks Equity Research
This collaboration is in line with Walgreens' (WBA) commitment toward providing affordable and convenient healthcare facilities to residents of North Carolina.
LabCorp to Expand Hematology Suite With Sysmex America Deal
by Zacks Equity Research
LabCorp (LH) will get to use Sysmex' advanced XN-9100 system, which is a scalable, modular automation system.
Walgreens Boots Alliance (WBA) Stock Moves -1.1%: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $54.70, moving -1.1% from the previous trading session.
Walgreens (WBA) Becomes Latest Retailer to Suspend Zantac Sales
by Christopher Vargas
Walgreens (WBA) announced today that they would be suspending the sales of Sanofi's (SNY) heartburn medication Zantac.